Audevard Overview

  • Founded
  • 1985
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 54
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 2
  • Investments
  • 1

Audevard General Information

Description

Operator of a pharmaceutical laboratory dedicated to equine health. The company manufactures medicines for acidity, intestine and digestion, creams and ointments for horse skin and food supplements, helping clients to improve health for competition horses, leisure horses and breeding horses.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Other Consumer Non-Durables
Other Industries
Pharmaceuticals
Primary Office
  • 42/46 rue Médéric
  • 92110 Clichy
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Audevard Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Audevard‘s full profile, request access.

Request a free trial

Audevard Patents

Audevard Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6276429-B2 Pergolide transdermal formulation and use thereof Active 18-Jun-2014 000000000
EP-3166642-A1 Transdermal formulations of pergolide and uses thereof Granted 18-Jun-2014 000000000
AU-2015277554-C1 Transdermal formulations of pergolide and uses thereof Active 18-Jun-2014 000000000 0
AU-2015277554-A1 Transdermal formulations of pergolide and uses thereof Granted 18-Jun-2014 000000000
AU-2015277554-B2 Transdermal formulations of pergolide and uses thereof Active 18-Jun-2014 A61K31/48 0
To view Audevard’s complete patent history, request access »

Audevard Executive Team (2)

Name Title Board Seat Contact Info
Marina Wissink Verzier President
Celine Munier Administrative and Financial Director
To view Audevard’s complete executive team members history, request access »

Audevard Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Audevard Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Audevard‘s full profile, request access.

Request a free trial

Audevard Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000é 00 26-Jul-2016 0000000000 Buildings and Property
To view Audevard’s complete investments history, request access »